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1. Introduction
Thermogenesis in brown adipose tissue (BAT) is
attributed to uncoupling of respiration which is
caused by a speci¢c component located in the inner
mitochondrial membrane, the uncoupling protein
(UCP-1). This review is con¢ned to the uncoupling
protein (UCP-1) from BAT. We summarize the
present status of our knowledge of the structure,
the characteristics of this membrane protein, the
function, the regulation of function, the interaction
with ligands, and the structure^function relationships
as elucidated by speci¢c reagents and by mutagene-
sis. Previous reviews [1,2] have also dealt with these
subjects but the rapid development in this ¢eld asks
for a new review. A recent brief survey deals prima-
rily with the work from the Ricquier group [3]. The
present article will not treat in detail the physiology
of UCP-1 in thermogenesis, the regulation in vivo,
the regulation of its expression by temperature and
other factors, the regulation of activity by hormones
and the signal transduction. Here excellent overviews
are available in the literature [2^4]. Recently, genes
have been described coding for uncoupling protein
isoforms (UCP-2 and UCP-3) which are expressed
also in tissues other than the BAT as deduced from
their mRNA distribution. These can be linked more
to obesity than thermogenesis [5^8]. However, there
does not yet exist a biochemistry of these uncoupling
proteins to speak of and therefore they will not be
treated here.
The biochemistry of UCP-1 started with the iso-
lation of the intact nucleotide binding protein from
BAT mitochondria [9,10]. This advance was based
on the ¢nding that BAT mitochondria could be re-
coupled by GDP [11]. Further a GDP binding site on
the outer face of the inner membrane was found
[12,13]. These results suggested that a nucleotide
binding protein was responsible for the uncoupling.
Subsequently, by photoa⁄nity labeling of BAT mi-
tochondria with azido [Q-32P]ATP, a 32 kDa compo-
nent was identi¢ed in SDS gels [14]. Since the ATP
binding capability and the molecular mass were sim-
ilar to the ADP/ATP carrier (AAC), the isolation of
this nucleotide binding protein from hamster BAT
mitochondria was initiated [9] under the working hy-
pothesis that it has a similar structure as the AAC.
Thus, essentially the same isolation methods (e.g.,
use of non-ionic detergents, hydroxyapatite step) pre-
viously developed for the isolation of the ¢rst intact
transporter, the AAC [15], were successfully applied
for the isolation of a protein from BAT mitochon-
dria which retained the nucleotide binding capability
[9,10].
In view of its putative uncoupling function we
christened this protein ‘uncoupling protein’ [9]. In
part of the literature (see, e.g., [2]) the same protein
was also called ‘thermogenin’. The primary structure
elucidated from the isolated hamster UCP-1 by ami-
no acid sequencing [16] vindicated the working as-
sumption of the similarity to AAC. The sequence
similarity of UCP-1 not only with AAC but also
with the subsequently sequenced mitochondrial phos-
phate carrier [17] led us to postulate the existence of
a homologous mitochondrial carrier family. This
view has been con¢rmed by the elucidation of further
mitochondrial carriers (reviewed in [18^21]). In the
meantime the sequences of UCP-1 from numerous
mammalian sources are known [22^27]. UCP-1 to-
gether with AAC and PiC forms a functional sub-
group of carriers linked to energy transfer in mito-
chondria. It is remarkable that similar proteins deal
with the transport of solutes which have an ex-
tremely di¡erent size, ATP and ADP being about
the largest and H the smallest transported solute
[28].
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2. Structure
UCP-1 from hamster consists of 306 amino acids
with a calculated molecular mass of 33.2 kDa. Of
these there are 28 basic and 19 acidic residues, result-
ing in an excess of 9 positive charges. An excess of
basic residues is also found in other mitochondrial
carriers such as the bovine heart ADP/ATP carrier
(+19 charges) [17] and phosphate carrier (+12
charges) [17,29]. Presumably some of the positive
charges are necessary for proper anchorage to the
phospholipid especially cardiolipin environment.
UCP-1 has been isolated using the non-ionic Tri-
ton X-100. This procedure yielded functionally intact
protein as shown by its nucleotide binding capability
[9] and H transport activity in the reconstituted
system [30]. In this soluble form, UCP-1 exists in a
large micellar structure with Triton X-100 and rem-
nant phospholipids. A homodimer structure (Mr 66
kDa) encircled by about 160 Triton molecules was
evaluated from analytical ultracentrifugation [31].
Evidence for the homodimer structure was also ob-
tained from a ‘half-site reactivity’ nucleotide binding
capacity of 16 Wmol GDP/g protein [10], and from
cross-linking experiments of UCP-1 as the isolated
protein [32] and in mitochondria [33]. The similar
Triton-protein micellar structures of UCP-1 and of
AAC [34] explain the striking passage of these pro-
teins in the intact state through hydroxyapatite. The
homodimer structure for UCP-1 is in line with an
early developed concept [35] that membrane proteins
form preferentially oligomers, in particular dimers
with the twofold axis perpendicular to the mem-
brane. This principle was ¢rst inferred from the
AAC structure [34] and has since been proven to
hold for many membrane proteins involved in solute
transport and also for the electron transport com-
plexes. Recently the importance of the homodimer
structure for transport function was elegantly dem-
onstrated with the mitochondrial phosphate carrier
[36], which is a homolog to UCP-1.
Based on the primary structure, a folding model of
UCP-1 was derived, which in its simplest form con-
tains six transmembrane K-helices [16,17]. A structur-
al model employing our present view is given in Fig.
1. The hydrophobicity pro¢le delineates transmem-
brane helices in UCP-1 only poorly because of the
intrahelical position of some charged residues. Here
we de¢ne tentatively the transmembrane helices as
being terminated by the characteristically repetitive
charged residues, in particular acidic groups. The
simple six transmembrane model ¢rst hypothesized
for the AAC [37] is to be modi¢ed. According to
the evidence presented below not only for AAC but
also for UCP-1, intermembrane loops protrude from
the matrix side into the membrane region. In the
original hydrophobicity analysis, even an amphi-
pathic L-chain was predicted based on strikingly al-
ternating amphipathic patterns comprising 12 resi-
dues from 36 to 48 on the matrix side [16]. The
meaning of this interesting ¢nding remains obscure
at present. Circular dichroism spectra (Appel and
Klingenberg, unpublished data) and infrared spectro-
scopy [38] indicate a 40% to 50% K-helical content of
UCP-1 in agreement with at least six transmembrane
helices.
A striking feature is the tripartite structure which
UCP-1 shares with the other members of the mito-
chondrial carrier family [17,37]. UCP-1 is divided up
into three similar domains containing about 100 ami-
no acid residues. Each domain comprises two trans-
membrane helices which are separated on the matrix
side by a large, about 40 residues long highly hydro-
philic stretch. It contains about 12 charged residues,
which are arranged in a repetitive manner. A char-
acteristic motif contained in UCP-1 common to the
other family members is the sequence PX (3) XX (+)
X (+) starting at the end of the ¢rst helix in each
repeat domain [17,39]. Another typical feature is the
occurrence of an arginine within the second helix in
each repeat domain. Conspicuously located intrahel-
ical negative residues speci¢c to UCP-1 are an Asp in
the ¢rst helix and a Glu near the end of the fourth
helix. The function of these residues has been ad-
dressed by site-directed mutagenesis (see below).
Experimental evidence for the topology of UCP-1
folding indicates that both the C- and N-termini are
directed towards the cytosol. Antibodies generated
against the N-terminal sequence reacted in mitochon-
dria indicating its protrusion towards the cytosol
[40]. In mitochondria but not in submitochondrial
particles a cysteine located near the C-terminal of
UCP-1 is cross-linked by membrane impermeant
Cu-phenanthroline [32]. A series of antibodies were
generated against a random population of peptides
expressed as MalE fusion protein. Antibodies against
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several peptides located on either the cytosol or the
matrix side were collected and the location of these
peptides on either side of the membrane was mapped
[41]. Thus a fairly complete picture in agreement with
the six transmembrane foldings was obtained, which
is re£ected in Fig. 1.
3. Transport by the uncoupling protein
3.1. Mitochondria
After many years of pioneering research by several
laboratories on the biochemical background of ther-
mogenesis by BAT, the application of chemi-osmotic
reasoning to BAT mitochondria by Nicholls and
coworkers [42^45] contributed much to our under-
standing of the thermogenesis as an uncoupling
caused by transport of H through the inner mito-
chondrial membrane. The argument for a high H
permeability was based on osmotic swelling experi-
ments with BAT mitochondria using K acetate [42].
Massive K acetate uptake into non-respiring mito-
chondria is facilitated by valinomycin-catalyzed K
uptake and the parallel di¡usion of acetic acid
coupled to the compensatory H release through
the inner mitochondrial membrane. The direction
of H transport in this case is opposite to the ‘un-
coupling action’. This method was useful in de¢ning
a high H and anion transport activity in BAT mi-
tochondria. Also with this method the activation of
H transport by FA [46] and the inhibition by nu-
cleotides were found [47,48]. In further studies only
the uncoupling of the respiratory rate was used to
Fig. 1. A folding diagram of UCP-1 from hamster BAT. The transmembrane organization relies on topological studies and on assign-
ing the transmembrane terminals to charged residues. Three intermembrane loops are assumed to exist between the three helix pairs,
based on the accessibility from the cytosol to membrane impermeant probes (see Section 6.1).
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indirectly estimate the H re£ux rate into the mito-
chondria [48] and its dependence on various param-
eters [44^46,48^50]. However, the use of mitochon-
dria has its limitations for a detailed elucidation of
the regulatory factors of UCP-1 because of endoge-
nous uncontrollable in£uences. For example, the un-
coupled respiratory rate is limited by the hydrogen
input from substrates and not by UCP-1 which can
have an up to 50-fold higher H transport capacity.
3.2. Reconstituted UCP-1
After isolation of UCP-1, it became desirable to
assay its function separately from the complex envi-
ronment in mitochondria and thus to elucidate var-
ious factors which in£uence H transport and even-
tually the mechanism of the uncoupling action.
Reconstitution for functional studies was slow in
coming after the isolation of UCP-1, but it has
greatly extended our knowledge of kinetic parame-
ters of H transport and of activating or inhibiting
factors.
The reconstitution recipe [30,51^54] requires some
steps which di¡er from the isolation of UCP-1 for
other purposes and also from the reconstitution of
other mitochondrial carriers. Whereas UCP-1 iso-
lated with Triton X-100 is the most stable form, it
is not suitable for reconstitution since traces of Tri-
ton cannot be removed and cause leakiness of the
vesicles for H and Cl3. The use of C10E5 for
UCP-1 was found to give the best results since it
does not delipidate UCP-1 as strongly as Triton X-
100 and is more easily removed. Among various
phospholipids, puri¢ed hen egg phosphatidylcholine
produced the tightest vesicles [30]. A stepwise remov-
al of the detergent with polystyrene beads yields rel-
atively large proteoliposomes with high activity.
With this procedure proteoliposomes can be pre-
pared either for H import or H export, by loading
with a high pH K-phosphate bu¡er (pH 8 to 9) or a
low pH Na-phosphate bu¡er (pH 6). H transport
is induced by valinomycin addition which generates a
K di¡usion potential either positive outside or in-
side. Reconstitution was performed in at least three
laboratories with some variations of the described
procedures [30,52,55]. The H transport can be
measured by a pH electrode or by pH indicators,
such as pyranine [56,57]. Indirectly H transport
has also been followed by using a £uorescent indica-
tor of the K £ux [57]. In a typical experiment the
H £ux is initiated by valinomycin until equilibrium
is reached according to the relation
Hi =He   Ki =Ke 
assuming that the membrane is permeant only for
H and K. Since Cl3 and other small anions are
also transported by UCP-1, their presence had to be
avoided in these measurements.
3.3. H+ transport and fatty acid requirement
H transport is generally accepted to be central to
the uncoupling activity of UCP-1, although there are
large di¡erences in opinion of how UCP-1 facilitates
the H transport. The research on H transport
deals with the mechanism of H transport and
with the parameters governing the H transport rates
especially the requirement for FA, and the regulation
of H transport by purine nucleotides. H transport
by UCP-1 is dependent on the presence of medium to
long chain FA. This was ¢rst inferred from studies
with mitochondria [48,49,58]. Reconstituted vesicles
permitted a more detailed insight into the structural
requirements of FA for activation [59]. Further, the
dependence on the concentration and on the pH
could be studied in detail [59]. Once traces of endog-
enous FAs are eliminated by bovine serum albumin,
H transport in proteoliposomes becomes absolutely
dependent on the addition of FA [30,54] whereas in
preparations of BAT mitochondria an active lipolysis
of adherent triglycerides may produce a constant
supply of FA. Further, phospholipase can produce
FA within the mitochondria. BSA may not be able
to catch FA taken up through the intimate contacts
between triglyceride globules and mitochondria.
Therefore even with BSA, the uncoupling activity
cannot be completely suppressed in mitochondria
[48,60].
The dependence on the amount of palmitate re-
quired for uncoupling in mitochondria was deter-
mined using BSA as a FA bu¡er [60]. A Km of
90 nM for palmitate was reported. However, we con-
sider this system too complex to permit this quanti-
tation. ATP and Mg2 additions were required for
the respiration. It is obvious that with several coun-
teracting factors a¡ecting UCP-1 activity, such as
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Mg2, ATP, BSA and FA, the system is frail with
uncertainties in£uencing UCP-1 activity. For exam-
ple, ATP inhibits UCP-1 whereas excess Mg2 abol-
ishes the inhibition. Also ATP, Mg2 interact with
BSA and in£uence the FA binding. The true
amounts of free FA may be much higher due to
continuous lipolysis in mitochondria which cannot
be completely removed by BSA. Thus the value of
Km 90 nM for palmitate can be a too low estimate.
Further, the uncoupling measurements relied on the
indirect measurements of respiratory activity.
In reconstituted vesicles these complications are
removed. The H transport activity can be measured
directly, avoiding the uncertainties of the H trans-
port capacity estimated from swelling and respiratory
rate stimulation. The H transport activity reaches
100 Wmol (mg protein)31 min31 at 12‡C. This value
is 90 times higher than required for uncoupling of
respiration as estimated from respiratory uncoupling
in BAT mitochondria [48], taking into account that
the mitochondria were measured at 25‡C and con-
tained 10% UCP-1 by protein weight. In vesicles
Table 1
The dependence of H transport activation on the structure of fatty acids
Fatty acids and derivatives Number of hydrophobic carbons Relative H uptake rate vV/VL*
Saturated
Lauric acid C12 = 1.0 (VL)
Palmitic acid C16 0.4
Stearic acid C18 0.1
Unsaturated
Oleic acid C18 1.02
Elaidic acid C18 0.85
Q-Linoleic acid C18 1.03
Q-Linolenic acid C18 0.90
Palmitoyl esters
Palmitoyl acid methyl ester 0.11
Palmitoyl-DL-carnitine chloride 0
Palmitoyl coenzyme A 0
Hydrophilic substituted
g-Bromo-lauric acid C12 1.31
g-Hydroxypalmitic acid C16 0.55
2-Bromopalmitic acid C16 1.81
2-Hydroxypalmitic acid C16 0.93
g-Carboxypalmitic acid C16 0.37
12-Azidooleic acid C18 1.03
12-Doxylstearic acid C18 0.69
g-Glucopyranoside palmitic acid 0.82
Fluorescent derivatives
Anthracene-9-carboxylic acid C15 0.02
4-(3-Pyrenyl)butyric acid C20 0.15
Diphenylhexatriene (DPH) propionic acid C21 0.13
Phenyl substituted
4-Phenylbutyric acid C10 0.11
6-Phenylhexanoic acid C12 0.25
8-Phenyloctanoic acid C14 0.57
10-Phenyldecanoic acid C16 1.16
Data obtained from H uptake measurements in UCP-1 proteoliposomes ([59] and unpublished data). FA concentrations 125 to
250 WM. *vV = V(+FA)3V(O). VL/CHW50 (min31 (mg protein)31).
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maximum H transport activity is obtained only
with surprisingly high amounts of FA, which can
reach up to 8 mol% of the phospholipids in the
vesicles [54,59]. Although most of the added FA
(oleic acid) was shown to be bound to vesicles, the
vesicles still remained tight. It must be assumed that
for activation of H transport UCP-1 recruits FA
primarily from the surrounding lipid phase. The
maximum H transport rates exceed by far what is
needed for the uncoupling of mitochondria but are
highly signi¢cant for evaluating the H transport
mechanism and its regulation in UCP-1. A physio-
logical signi¢cance of high FA requirement is under-
lined by the ¢nding that very high FA concentrations
(up to 20 mM) occur in BAT on activation of lip-
olysis [61].
Why is there such a high level of UCP-1 of up to
10% of protein present in BAT mitochondria if with
its high capacity much less UCP-1 could accomplish
the uncoupling? No simple answer can be given at
present, but the following arguments may give a rea-
sonable explanation. UCP-1 in mitochondria is in-
hibited by ATP. At least four parameters in£uence
H transport activity by UCP-1, ATP43 concentra-
tion, FA ‘concentration’, pH and vi. With a total
concentration of cytosolic ATP = 3.6 mM [62,63] and
2 mM Mg2, the free ‘ATP43’ in brown adipocytes is
calculated to be about 35 WM and thus would inhibit
UCP-1 at pH 6.8 to more than 95% of its maximum
capacity. In the activated state, a decrease in ATP
concentration to 0.8 mM [62,63] and an increase of
cytosolic pH to s 7.5 would lower ATP binding to
80% due to much lower a⁄nity of ATP for UCP
[64]. In perfused liver a strong pH increase was ob-
served when FAs were supplied [65]. The free UCP-1
might have submaximum activity due to limited ac-
cess of FAs and because of the low vi which results
from the balance of uncoupling and electron trans-
port activity.
3.4. Fatty acid speci¢city
Surprising is the non-speci¢city towards FA and
derivatives within certain limits [48,59,66]. There is a
minimum requirement for the chain length of FA
(Fig. 2). Whereas C-8 acid (caprylic acid) starts to
have a marginal activity, the activity quadruples with
C-10 (decanoic acid) and increases another 1.5-fold
reaching maximum with C-14 (myristic acid). It de-
creases with C-16 (palmitic acid) and more strongly
with C-18 (stearic acid). The lower activity of C-16 to
C-18 is due to the poor aqueous solubility of these
saturated FAs. The more soluble oleic acid (vC-18)
is nearly an as good activator as C-14. FA deriva-
tives in which part of the alkyl chain are replaced by
a phenyl group, such as phenyl hexanoic and phenyl
butyric acids, are still fair activators (Table 1) [59].
Obviously, not an exactly de¢ned structure such as a
linear alkyl chain, but more a minimum hydropho-
bicity balance is essential for activity. Checking the
activity with FA derivatives containing hydrophilic
substitutions is interesting for mechanistic reasons.
g-Hydroxy and g-bromo substitutions still permitted
fair to high activities. Even FAs, where highly hydro-
philic and large substituents (e.g., carboxyl and glu-
copyranoside) are introduced at the g-position, still
permitted a signi¢cant stimulation. Substitution at
C-12 and C-18 by azido or doxyl (spinlabel) groups
did not markedly inhibit the activity ([59] and Table
1). These results indicate a minimum requirement of
only su⁄cient lipid solubility and of a free carboxyl
group. At variance with our results, Jezek et al. [66]
recently reported no activity with phenyl substituted
FA using indirect H transport measurements.
Fig. 2. The dependence of H transport activity on the chain
length of FA [59]. Measurements of H uptake in UCP-1 pro-
teoliposomes in the presence of 100 WM FA. The decrease in
activity with the FA chain length above C14 is due to the low
solubility. The dashed line represents residual H transport
measured in the presence of excess external GTP.
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The pH dependence of H transport is of great
interest because of its mechanistic implications since
it should re£ect the dissociation of groups involved
in H transport. As measured in proteoliposomes,
H transport activity by UCP-1 increases with the
pH, reaches a maximum and slowly falls o¡ [30,54].
The pH maximum depends on the chain length of
the FA. With short-chain FA such as C-8 and C-10
the pH maximum is low (pH 6 to 6.5) and then
increases with the chain length reaching maximum
at pH 8.0 with oleic acid (Winkler and Klingenberg,
unpublished data). This increase of the pH maximum
coincides with the known pKa upshift of the FA with
increasing chain length when bound to membranes
[67]. The pKa upshift is due to the increased hydro-
phobicity in the environment around the carboxyl
group, in addition to other entropic e¡ects. Electro-
philic substitutions (e.g., bromo-substitution at the
C-2 position) lower the pKa of the adjacent carboxyl
group. Accordingly, H transport activated by 2-
bromo-palmitic acid had a pH maximum at 6.8
which is distinctly lower than that of the palmitic
acid (Winkler and Klingenberg, unpublished data).
The threefold higher activity as compared to palmitic
acid (Table 1) is partially due to the better solubility
of the 2-bromo derivative.
3.5. Anion transport
The particular permeability of BAT mitochondria
to small anions was ¢rst described by Nicholls and
Lindberg [42], by measuring the osmotic swelling of
mitochondria in the presence of K-salts and valino-
mycin. This anion transport is highly unspeci¢c and
tolerates also Br3, NO33 and several other non-cova-
lent anions. In fact, the transport of anions other
than Cl3, e.g., NO33 , is up to eightfold faster. This
anion transport is inhibited by GDP which is the
criterion for the involvement of UCP-1. Interestingly,
when puri¢ed UCP-1 was reconstituted into asolectin
‘giant liposomes’ Cl3 channel properties could be
demonstrated in patch-clamp studies [68]. The 75-
pS channel could be inhibited by GTP, GDP but
not by AMP, in accordance with the nucleotide bind-
ing properties of the UCP-1.
Anion transport, particularly Cl3 transport, was
measured in reconstituted system using either 36Cl3
[30,53] or anion-sensitive £uorescent dyes [30,57].
Also in the reconstituted system Cl3 transport did
not require FAs. However, there is controversy on
whether FAs inhibit Cl3 transport. Both on the level
of mitochondria and in the reconstitution system no
competition has been found by the groups of Rial
and Nicholls [48] and Winkler and Klingenberg (un-
published data). At variance, Jezek et al. [57] re-
ported a competition of Cl3 transport by laurate
using SPQ, a £uorescent indicator for Cl3. This com-
petition is used as one of the arguments for the tenet
that FAs are transported as anion by UCP-1 [57,69].
A reasonable explanation is that the FA-activated
H transport and the concurrent Cl3 transport com-
petes for the limited capacity of the membrane dif-
fusion potential generated by valinomycin plus K,
which drives both H and Cl3 transport in opposite
directions. The much more active H transport thus
suppresses the Cl3 transport, which is lower than the
H transport activity by a factor of 5 to 20 in the
reconstituted system [56,57].
Jezek and Garlid [70] reported the transport of
alkyl (C3 to C6) sulfonates in BAT mitochondria as
judged by the swelling assay. However, with in-
creasing chain length (C6-sulfonate), the apparent
swelling became less GDP sensitive. A competition
between alkyl sulfonate and GDP was invoked.
This is in contradiction to the evidence presented
by these authors that the GDP binding site does
not overlap with the anion channel [71]. Moreover,
the same authors demonstrated that Cl3 transport
and GDP inhibition are uncompetitive [57]. Neder-
gaard and Cannon [72] reported a competition of
hexanesulfonate with GDP binding, however, only
at very high concentrations with a Ki of 13 mM,
which could partially explain the insensitivity to
GDP. To some extent, at the high concentrations
used of 54 mM [70], alkyl sulfonates can also take
a UCP-1-independent pathway and have a deter-
gent type e¡ect on the membrane which mimics
the swelling. They also showed that short-chain al-
kyl sulfonates strongly compete with Cl3 transport
and concluded that they are transported even more
actively than Cl3 by UCP-1 [70]. A longer chain
alkyl sulfonate, C11-sulfonate, was shown to inhibit
the lauric acid-stimulated H transport [69]. Up-
take of C11-sulfonate was measured indirectly by
the stimulation of valinomycin dependent K in-
£ux.
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3.6. Common or di¡erent paths for H+ and Cl^
The existence of separate channels for H and Cl3
transport was claimed by Kopecky et al. [47] by com-
paring H transport and Cl3 uptake in BAT mito-
chondria. However, the evidence is not convincing as
pointed out by Rial et al. [48]. Rial and coworkers
also discussed that FAs might induce a conformation
change in UCP-1 [48]. Since the Cl3 transport did
not require FAs, this model might imply that H and
Cl3 transport use separate pathways. Therefore the
activation by FA through a conformation change of
UCP-1 seems unlikely (see below). A further argu-
ment for a common channel is the equal sensitivity to
nucleotides of both H and Cl3 transport ([48,71];
Winkler and Klingenberg, unpublished data). A
common channel for H and Cl3 is well de¢ned in
halobacterial retinal protein [73]. The selectivity for
H and Cl3 is here modulated through the elimina-
tion or introduction of aspartyl groups. One may
argue that a channel engineered for H transport
would not be able to transport Cl3. However, one
has to consider that the Cl3 transport rate is much
slower and must be regarded as a kind of side reac-
tion of the H channel. Finally one may ask: could
proteins as small as UCP-1 accommodate two di¡er-
ent transport channels in parallel? This seems to be
improbable in view of the larger size of most other
transport and channel proteins.
3.7. The in£uence of vi on H+ transport
In line with the uncoupling function, H transport
in BAT mitochondria is driven by the membrane
potential. In the proteoliposomes a clear linear rela-
tion between the rate of H transport and vi gen-
erated by the K gradient was demonstrated [30,54].
Also in BAT mitochondria a linear relation between
vi and FA stimulated respiratory rates, as a meas-
ure of uncoupling by H recycling, was reported [74].
However, the point was made that in the presence of
GDP the decreased H conductance at low vi
(9150 mV) is transformed into a high conductance
at elevated membrane potentials. As a result the H
conductance follows a non-linear or ‘non-ohmic’ re-
lation. Previously such a relation has been measured
in liver mitochondria with a breakpoint to high con-
ductance at about 180 mV [43]. This phenomenon
was also described as ‘slippage’. In BAT mitochon-
dria the threshold for the appearance of high con-
ductance is shifted by FAs down to about 130 mV.
In this terminology, FAs increase slippage more in
BAT than in liver mitochondria. Since this FA-in-
duced shift is seen only in mitochondria from BAT
but not from liver, it was argued that FA can acti-
vate even GDP-saturated UCP-1. In essence, the
high v8 has to override the inhibition by GDP in
cooperation with the FA. How this is mechanistically
accomplished remains unknown. The physiological
role of this e¡ect in BAT will be questioned below.
3.8. Mechanism of H+ transport by UCP-1 and the
role of fatty acids
In a way, UCP-1 is the simplest H transporter
known. It does not require a complex ATPase driven
H transport machinery, it does not involve a H-
substrate cotransport and is not, for example, a H
exchanger against Na or Ca2. H transport in
UCP-1 is simply driven by the membrane potential.
In a sense UCP is more a carrier than a channel for
H ; it requires additional catalysts for its transport
and is structurally related to mitochondrial solute
carriers. H transport in general has been treated
extensively in the literature both from a theoretical
and experimental point of view. Theoretically, H
transport is fascinating because of the very low H
concentrations at normal pH and the dependence of
H transport on chains of H2O molecules along
which H are conducted. The installation of H do-
nor/acceptor groups within a channel in addition to
the H2O molecules is crucial for providing a su⁄-
cient H transport capacity. Further, H donor/ac-
ceptor groups enable unidirectional H transport by
providing a pKa gradient. Under the in£uence of v8
the pKa may be changed to generate this gradient
along the translocation channel. In bacteriorhodop-
sin [75,76] and cytochrome oxidase [77], H donor/
acceptor groups have been identi¢ed by site-directed
mutagenesis to be represented by the carboxyl
groups of Asp and Glu within the well de¢ned
atomic resolution structure. The identi¢cation of po-
tential H acceptor/donor groups in UCP-1 by muta-
genesis will be discussed below.
Within the realm of this general picture, H trans-
port in UCP-1 is distinguished by its requirement of
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FA. This absolute requirement gives FA a role as
cofactor for H transport in UCP-1. According to
our working hypothesis [59], FAs provide carboxyl
groups in the translocation channel. They may com-
pensate for the absence of resident H donor/accep-
tor groups at some critical positions within the H
translocation channel. A somewhat similar model
(Fig. 3A) has been discussed by Rial et al. [48] as
a possible alternative to their conformational model.
Here the carboxyl groups of the FAs oscillate along
the translocation channel carrying the H. This
model does not involve the possible intervention of
resident carboxyl groups provided by Asp or Glu in
the translocation channel. According to our model
(Fig. 3C) [59,78], in addition to the resident H do-
nor/acceptor groups, the FA may ¢ll one or more
gaps in the translocation channel. In fact, site-di-
rected mutagenesis provides evidence for the exist-
ence of resident H donor/acceptor groups [79]
(see below). This construction of the H transport
machinery in UCP-1 permits the regulation of the
uncoupling activity by changes of FA ‘concentra-
tions’. The low a⁄nity as evidenced by the high
amounts of FA required for maximum stimulation
[54,59] enables regulation over a wide range of FA
concentration. In other words, FAs are not sticking
to UCP-1 and can allow a rapid return of UCP-1
into the inactive state. In this context it should be
noted that FA binding to UCP-1 was claimed to be
demonstrated by using spinlabeled (doxylstearic
acid) FA [80]. However, the line broadening in these
ESR spectra is not uniquely due to a speci¢c binding
to UCP-1 but may be caused by adsorption to pro-
tein detergent interfaces. With g-azido lauric acid,
inhibition of H and Cl3 transport was also re-
ported [81]. On photoactivation of the azido-FA,
radioactive labeling in mitochondria, preferentially
of UCP-1, was shown. However, no data on the
amount of incorporated azido lauric acid were given.
One has to consider unspeci¢c covalent incorpo-
ration from the excess of highly reactive nitrene de-
rivative of lauric acid generated in the membrane
[82].
A model for the mechanism of FA function repre-
senting our present view is given in Fig. 4. It is as-
sumed that FAs mainly act from the cytosolic side of
the membrane since g-glucopyranoside palmitic acid
is anchored to the outer surface. The FA carboxyl
can penetrate from the interface of the protein to a
H acceptor group. This area may be comparatively
unspeci¢c, i.e., the protein provides a favorable, par-
tially hydrophilic environment for a movement of the
Fig. 3. Variant models for the role of fatty acids in H transport by UCP-1. (A) Conformational activation of the H transport path-
way by FA. (B) Cofactor role of FA by providing H translocating groups. (C) Cofactor role of FA by providing H translocating
groups in addition to resident groups (Asp/Glu), where FAs ¢ll gaps in the H translocating path. (D) FA anion transport shuttle.
FAs are translocated as anions by UCP-1 and reshuttle though the membrane as undissociated acids.
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carboxyl towards the H acceptor. The ¢nal H do-
nors are His-145 and His-147 which serve to push
H into matrix [79]. In this ‘lower’ section, the H
path is within the protein and thus here the control
by the nucleotide induced conformation change is
located. This model is in line with the structural
model (Fig. 1) with three loops extending from the
matrix into the membrane. These may provide the
path for H and also a compact selection ¢lter anal-
ogous to the structure recently described for the K
channel [83].
3.9. Variant models of H+ transport mechanisms
Mechanisms of FA activation of H transport by
UCP-1 have been discussed also in terms of an ac-
tivator rather than a cofactor role by Rial and
Nicholls [48]. For example, as indicated in Fig. 3A,
FA may activate the H translocating channel by a
conformational change. Also a surface membrane
potential e¡ect caused by FA was discussed [48]. A
quite di¡erent role of FA is visualized in the anion
transport model of FA activation of UCP-1 (Fig.
3D) [57]. Originally this model had been proposed
by Skulachev [84] based on the observation that
the FA-induced uncoupling of mitochondria can be
partially inhibited by carboxyatractylate, a speci¢c
inhibitor of the AAC [85]. The AAC was speculated
to transport FA anions and this model was then
extended to explain the activation by FA of H
transport in UCP-1. In this model UCP-1 is not an
actual H transporter but a transporter for FA
anions. Once FA anions are transported through
UCP-1, they pick up or release H on either side
of the membrane and £ip-£op as undissociated FAs
through the lipid bilayer (Fig. 3D). As a result, H is
transported through the membrane in the opposite
direction to the FA anion transport by UCP-1. Re-
cently the model has been modi¢ed such that the FA
anions are translocated on the interface between
UCP-1 and the membrane [69]. Studying anion
transport in BAT mitochondria and in the proteo-
liposomes, Jezek and Garlid [57] claimed to have
veri¢ed the FA anion transport in UCP-1 with the
demonstration of the alkyl sulfonate transport as
model of FA anions.
Since alkyl sulfonates, because of their low pKa,
cannot £ip through the membrane like undissociated
FAs, it is reasoned that they perform the anion
transport branch via UCP-1 mimicking FA anion
transport. However, the experimental evidence is
weak as C11-sulfonate is needed for inhibition of
H transport at a 50-fold higher concentration
than laurate to activate H transport. Further, the
poor inhibition by external GDP argues that much
of the C11-sulfonate did not pass through UCP-1 but
was driven through the membrane by the K gra-
dient in a ternary complex formed with valinomycin
and K.
The £ip-£op of undissociated FAs is an essential
part of the FA anion transport model. Evidence
against FA £ip-£op playing a role in UCP-1 linked
transport comes from the fact that FA with hy-
drophilic tails, such as g-carboxyl palmitic acid
[59] or g-glucopyranoside palmitic acid (Table 1)
(Winkler and Klingenberg, unpublished data) are
also activating H transport, albeit only to about
50% of the maximum with lauric acid. The strong
hydrophilic tail should remain on the surface and
thus prevent any di¡usion through the membrane.
Fig. 4. A version of the role of FA based on recent evidence.
(a) Site-directed mutagenesis shows the existence of resident H
translocating groups and (b) H transport activation by mem-
brane impermeant FA derivatives such as g-glucopyranoside
(G3) palmitate (Winkler and Klingenberg, unpublished data).
The FA is assumed to participate in H transport from the c-
side. The FA active in UCP-1 is in equilibrium with FA located
in the lipophilic phase of the membrane. A1 and A2 are H ac-
ceptor/donor groups in UCP-1.
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The limited movement also lowers the activation
radius of the FA and explains the reduced activation
capability. Recently Jezek et al. [66,86] compared the
ability of various FA derivatives to ‘£ip-£op’ with
their ability to activate H transport, and concluded
a parallelism between both activities in support
of their FA anion transport model. The inactive
derivatives encompassed phenyl substituted FA
which, however, have been shown to be active in
our hands (Table 1). Surprisingly, the g-hydroxyl
or amino-substituted lauric acids are reported to be
inactive whereas the g-bromo derivative is highly
active.
4. Nucleotide binding
4.1. Equilibrium methods and nucleotide binding
speci¢city
Nucleotide binding by UCP-1 has been a key in
identifying [12,14] and isolating this H transporting
protein [9,10]. It has also provided a means for as-
saying the functional intactness of UCP-1 [87] and
understanding how the H transport activity is regu-
lated [1,47,64,88,89]. Nucleotide binding has been
measured to mitochondria [90,12,91] and extensively
to the isolated protein [10,64,88,89,92] and to UCP-1
reconstituted into liposomes [30,54,89]. Measure-
ments of nucleotide binding to the mitochondria
were limited by enzymatic degradation of the adenine
nucleotides [93,91] and therefore guanine nucleotides,
particularly GDP, were used in the binding studies.
Binding measurements to the isolated protein used
equilibrium dialysis [9,10], and a speci¢cally devel-
oped anion exchange method [87] based on the rapid
removal of free nucleotide by the anion exchanger.
Critical to the latter method is the slow dissociation
of the tight UCP-1-nucleotide complex.
UCP-1 accepts a broad range of nucleotides but
with strong preference to the purine nucleotides
[10,64]. GTP, ATP, GDP and ADP bind with high
a⁄nities (Kd = 0.3 to 3 WM at pH 6.7). Guanine nu-
cleotides exhibit somewhat higher a⁄nities than the
adenine nucleotides. The monophosphates GMP and
AMP are poor ligands which bind with over 50-fold
lower a⁄nities. The interaction with purine nucleo-
tides is a common denominator among UCP-1 and
AAC. However, there are several important and in-
teresting di¡erences, which are also relevant for
understanding carrier function in general [28,94].
Whereas UCP-1 binds both guanine and adenine nu-
cleotides, transport by AAC is highly speci¢c for
ADP and ATP. Some interaction with guanine nu-
cleotides was observed with NMR [95]. Monophos-
phate nucleotides interact very weakly with both car-
riers. In UCP-1 nucleotide binding causes inhibition
of carrier activity, while in AAC ADP or ATP acti-
vates the carrier into the transport state. The binding
a⁄nity is much higher in UCP-1 than in AAC. Nu-
cleotides bind only from the c-side in UCP-1 but
from both sides in AAC. Protease resistance experi-
ments showed that nucleotides render the UCP-1
into a more rigid state [33,89], while these ligands
labilize the AAC structure [96]. From the ‘induced
transition-¢t’ theory for carriers [28] it follows that
the intrinsic interaction force can be lower in UCP-1
than in AAC because it only transforms the protein
into the inhibited state, whereas in AAC a higher
intrinsic binding energy is required for the activation
of the large conformational changes from the ‘c-’ to
‘m’-state transition. Vice versa, a higher intrinsic in-
teraction energy can be deduced from the high spe-
ci¢city for adenine nucleotides in AAC as compared
to the tolerance for adenine and guanine nucleotides
in UCP-1.
Fluorescent 2P-O-dansyl nucleotides have enabled
both equilibrium and kinetic binding studies [88].
These derivatives of NDP and NTP bind with sim-
ilar a⁄nities as their parent nucleotides to UCP-1
with 10- to 30-fold £uorescence increase. Remark-
ably, although AMP binds weakly to UCP-1, dansy-
lation enhanced its a⁄nity by nearly 50-fold, thus
enabling dansyl-AMP binding measurements. The
£uorescent nucleotides were applied to measure
binding to isolated UCP-1 [88], to UCP-1 reconsti-
tuted into phospholipid vesicles [89] and to BAT
mitochondria [91,97]. Dimethylaminonaphthoyl
(DAN) nucleotides, which were previously applied
to study the ADP/ATP carrier [98], bound also
with enhanced £uorescence to UCP-1 [88,99]. How-
ever, NMR analysis showed a mixture of 60% 3P-O-
DAN and 40% 2P-O-DAN substitutions, whereas
there is 100% 2P-O-dansyl substitution [88]. The
DAN-nucleotide analogs may therefore not be suit-
able for kinetic studies.
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4.2. One or two nucleotides bound per UCP-1 dimer?
A binding capacity of 16 Wmoles GDP/g protein
was measured by equilibrium dialysis [9], corre-
sponding to a stoichiometry of 1 nucleotide/UCP-1
dimer. In all further binding studies in our labora-
tory the binding never exceeded this value, which is
critical to the question whether the stoichiometry is 1
or 2 nucleotides bound per UCP-1 dimer. There is
admittedly some uncertainty on the UCP-1 content
in these determinations. The report by Feil and Ra-
fael [93] that the stoichiometry was 2 GDP/UCP-1
dimer was based on immunological quantitation of
UCP-1 content, a method which is very di⁄cult to
calibrate reliably. Measurement of nucleotide bind-
ing was also attempted by quenching of the protein
tryptophan £uorescence [100]. The binding stoichi-
ometry of 2 GDP/UCP-1 dimer deduced from these
studies is £awed by guanine nucleotide and Triton
absorbance at 290 nm which causes the ‘inner-¢lter
e¡ect’. The maximum quenching is actually rather
small (2%) with UCP-1 isolated in reduced Triton
(Huang, unpublished data). With ADP and ATP
this interference is absent. Titration with ADP and
ATP of UCP-1 isolated in non-UV absorbing non-
ionic detergent emulphogen arrived at 1 ADP/UCP-1
dimer (Klingenberg and Appel, unpublished data).
The binding of only one nucleotide per UCP-1 dimer
may indicate an anti-cooperative e¡ect of the two
subunits in the UCP-1 dimer, i.e., binding of one
nucleotide molecule to one monomer inhibits the
binding to the counterpart either simply for sterical
reasons or more probably by inducing a non-binding
state on the other subunit [101,102]. Alternatively, a
single nucleotide binding site is constructed near the
interface of both subunits.
4.3. pH dependence of binding
One of the most remarkable features of nucleotide
binding to UCP-1 is its strong pH dependence, which
was ¢rst noted in mitochondria [90] and then studied
in great detail with isolated UCP-1 [10,64,88]. A sim-
ilar pH dependence was reported in urea-treated
membrane vesicles by Rafael and coworkers [103].
In the broad pH range studied by these authors,
the dependence largely agrees with the previous ob-
servations [10,64,88], except for the decrease in pKd
for GDP and ADP at pH6 4.5. The decrease in pKd
could not be explained by our pH dependence model
[64,88], but rather could have resulted from instabil-
ities under these extreme conditions (low pH and
37‡C).
Both NTP and NDP exhibit a strong pH depend-
ence but with well de¢ned di¡erences (Fig. 5). The
a⁄nity (pKD) decreases with pH, with a ‘break’ in
the pKD/pH curve at around 6.8 to the downside.
The slopes (vpKD/vpH) change from W30.2 to
31. Above pH 7.0 to 7.2, the slope (vpKD/vpH)
becomes steeper at 32 with NTP but not with
NDP. The pH dependence was interpreted by an
interplay of H dissociations at the nucleotide termi-
nal phosphate (pKa = 6.5) and at two constituent res-
Fig. 5. pH dependence of nucleotide binding to UCP-1 exempli-
¢ed with ADP and ATP (data taken from [64]). Measurements
with puri¢ed soluble UCP-1 by the anion exchanger method.
The line drawn through the measured points is based on a
model (a) accounting for the pKaW6.8 of ADPH23 and
ATPH33 dissociation, (b) assuming 100- and 50-fold higher af-
¢nity of ADP33 and ATP43 to UCP-1, (c) assuming regulation
by a carboxyl group with pKaW3.8 in UCP-1 which allows
binding of ADP and ATP only in the undissociated form (R-
CO2H), and (d) regulation by a His for the binding exclusively
of the nucleotide triphosphates ATP (GTP), by postulating that
binding requires HisH (pKaW7.2).
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idues with pKa = 3.8 and 7.2. UCP-1 was proposed to
exist in a binding and a non-binding state [64,88],
depending on the protonation of a putative Glu/
Asp residue (now identi¢ed as Glu-190) (Fig. 6). In
the non-binding state, this group forms an internal
ion pair which bars the entrance to the binding pock-
et for the nucleotide phosphate moiety. On protona-
tion of this strategically located Glu/Asp the nucleo-
tide binding site opens and is ready to accept the
ligand. The terminal phosphate (pKa = 6.5) of nucleo-
tide imposes a pH dependence by di¡erential binding
of the protonated forms NTPH33 and NDPH23 ver-
sus the deprotonated forms NTP43 and NDP33. Best
¢ts of binding data revealed a 50-fold stronger a⁄n-
ity for NTP43 over NTPH33 and a 100-fold stronger
a⁄nity for NDP33 over NDPH23. Thus, although
the population of the stronger binding species
NTP43 and NDP33 increased with increasing pH,
UCP-1 is transformed progressively into the non-
binding state due to deprotonation of the essential
Glu/Asp. These counteracting e¡ects result in a
rather £at pH dependence at pH6 6.5.
At higher pH, nucleotide binding is limited by the
availability of UCP-1 that is in the binding state.
This superposition explains the observed slope of
vpKD/vpH =31. A second residue in the protein
with pKa = 7.2 further contributes to the pH depend-
ence for NTP binding only. Upon protonation of
this putative histidine residue, the binding center is
assumed to be deepened which then can accommo-
date the triphosphate moiety for NTP binding [88].
Thus, superimposed to the protonation of Glu/Asp,
the a⁄nity for NTP declines with a slope of 32 on
the pKD/pH plot. This model was vindicated by the
identi¢cation of these two participating residues by
chemical modi¢cation [104] and by mutagenesis
[56,79].
4.4. Kinetics of binding
Kinetics of nucleotide binding were measured with
£uorescent 2P-O-dansyl nucleotides by stopped-£ow
£uorimetry [88]. Initial association rates were meas-
ured with kon = 4U105 M31 s31 (pH = 6.3, 25‡C) and
were largely independent of the nucleotide species.
The strong pH dependence of the association rates
with a slope vpkon/vpH = +1 suggest that protona-
tion of UCP-1 had to occur prior to nucleotide bind-
ing, consistent with the role of the putative Glu/Asp
as a binding^non-binding switch. Dissociation ki-
netics were followed by the decrease in the £uores-
cence due to dissociation of the UCP-dansyl nucleo-
tide complex on addition of a large excess of ATP.
The dissociation rates were low and strongly depend-
ent on nucleotide. A drastic di¡erence in the pH
dependence of the dissociation rates between dan-
syl-NTP and dansyl-NDP was observed. The pkoff /
pH plot for NDP was fairly £at while the plot for
NTP gave a slope of 31, in line with the results for
the pKD/pH dependence. Such a pH dependence can
be explained by the two-stage binding model, in
which this putative His is involved only in the bind-
ing of NTP [88] (Fig. 6). Within this model, the nu-
cleotide is assumed to bind rapidly to form a loose
UCP-nucleotide complex, which undergoes a slow
conformational change into a tight complex. NTP
binding requires exclusively the protonated histidine
(HisH). The dissociation of NTP is preceded by
the deprotonation of this HisH with a concomitant
conformation transition back to the loose complex
where it can dissociate rapidly from UCP-1. During
the dissociation of NDP, UCP-1 returns directly
to the loose state without deprotonation of the
HisH.
4.5. The two-stage (loose^tight) nucleotide binding
model
The anion exchange method yielded binding ca-
pacities consistently lower than the £uorescence titra-
tion. The binding capacity was 10% lower for dansyl-
GTP and even 50% for dansyl-ATP [88]. Two com-
plexes, one loose and one tight, were proposed to
account for this discrepancy (Fig. 6). It is further
assumed that the £uorescence method measured the
total binding comprising the two complexes, whereas
the anion exchange method determined only the tight
complex due to a rapid dissociation of the loose
complex during passage through the Dowex column.
In accordance, a concomitant conformation change
could be inferred from the sensitivity towards tryptic
digestion [33,89]. Cleavage by trypsin at Lys-292 of
the cytosolic protruding C-terminal stretch was dif-
ferentially inhibited by various nucleotides. Nucleo-
tides that bound tightly and inhibited the transport
protected more strongly than loose-binding non-in-
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hibitory derivatives such as DAN-ATP, DAN-ADP,
and dansyl-AMP [89].
Additional experimental evidence in support of the
two-stage mechanism recently came from kinetic
binding data [92]. The experiments showed a burst
of initial binding, re£ecting formation of the loose
complex. The subsequent slow phase represented
the gradual formation of the tight complex. The
binding data could be best ¢tted with equations de-
rived from the two-stage binding mechanism [92].
The individual parameters (Table 2) for the two-
stage binding have been de¢ned [88,89,92]. The initial
association rate is fast (4U105 M31 s31), as meas-
ured for the dansyl nucleotides. The conformational
transition was much slower for NTP than for NDP.
Both the forward k1 and backward k31 transition
rates were strongly dependent on pH and tempera-
ture. Apparently increasingly precise ligand recogni-
tion occurs at the slow conformational transition
step accompanied by maximum interactions between
the protein and nucleotide. The intrinsic dissociation
constant Kd for the loose complex (UCPcN) is about
2 WM. The overall KD varies and depends on the
nucleotide species. A large di¡erence was demon-
strated in the equilibrium distribution of the tight
and loose complexes. Here K
0
c k1=k31 de¢nes
the ratio of tight complex (UCP*WN) to loose com-
plex (UCPcN) at equilibrium. GTP, ATP, GDP and
dansyl-GTP form s 90% and ADP, dansyl-ATP and
dansyl-ADP form 40% to 70% tight complex. In con-
trast, dansyl-AMP and DAN-ATP form little
(6 20%) tight complex. As a result, dansyl-AMP
could reactivate the H transport activity in recon-
stituted UCP-1 which had been inhibited by ATP,
obviously by transferring UCP-1 into the loose trans-
port-active state.
Fig. 6. Two-stage (loose^tight) nucleotide binding model based on kinetic, equilibrium and pH dependence data. The UCP-1 is as-
sumed to exist in binding/non-binding states depending on the protonation at E190. A neighboring carboxyl group [125] is proposed
to pull the protonated His (HisH) whereby the binding center is deepened. In this state both NTP and NDP can bind, whereas only
NDP can bind when the His is in the neutral form. The binding proceeds with a rapid formation of the loose complex and a slow
conformational change into the tight complex.
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4.6. In£uence of ions and temperature
Mg2 was shown to decrease the apparent a⁄nity
of nucleotide binding [64]. More detailed studies
[91,103] revealed that Mg-ATP bound to UCP-1
with negligible a⁄nity. Rial et al. [48,90] reported
only a 10-fold lower a⁄nity of ATP in the presence
of 2 mM Mg2. Since Mg2 is present in the cytosol
in millimolar concentrations, the free ATP as an ef-
fective regulator should represent only a small frac-
tion of the total cytosolic ATP.
Anions were shown to compete with nucleotide for
binding to UCP-1 [10,88]. The potency of interaction
is: pyrophosphate (Ki = 0.16 mM)s sulfate (1.0
mM)s phosphate (4.4 mM)smaleate (8.0)s chlo-
ride (9.3 mM)Eacetate. Acetate displayed nearly
no inhibitory e¡ect, probably due to a more dis-
persed negative charge and therefore acetate is
recommended whenever a salt has to be present in
the binding measurements. The equilibrium binding
of dansyl-nucleotides to UCP-1 showed little
temperature dependence [88]. The high a⁄nity was
ascribed to a remarkably high entropy change
(vS = 136 J deg31 mol31) that was indicative of
strong ionic interactions associated with removal of
H2O molecules from the binding site. The kinetics
were strongly temperature dependent, requiring a
rather high (V60 kJ/mol) activation energy for
both the binding and dissociation of dansyl-ATP.
4.7. The masking/unmasking phenomena
The level of UCP-1 in BAT is strongly regulated in
accordance with the thermogenic requirements.
Changes in UCP-1 content on warm- or cold-adap-
tation of laboratory animals have been well docu-
mented [105^107]. In all experiments, these authors
observed a correlation between the UCP-1 content in
BAT mitochondria and the thermogenic capacity us-
ing GDP binding as an index.
An acute change of the environmental temperature
produced a discrepancy between the GDP binding
sites and UCP-1 content. When rats raised at 27‡C
were transferred to 4‡C for only 20 min, GDP bind-
ing to the isolated mitochondria was found to in-
crease 1.3-fold [108], although no de novo synthesis
of UCP-1 had occurred under these conditions [105^
107]. These ¢ndings suggested that the nucleotide
binding sites in BAT mitochondria could be ‘un-
masked’ to cope with the acute temperature change.
Acute unmasking of binding sites could also be
achieved with norepinephrine and L-adrenoreceptor
agonists [109^112]. Alternatively, the binding sites
could be ‘masked’ on warm adaptation of the ani-
mals [107].
Various hypotheses for the unmasking have been
discussed previously by Nicholls and Locke [4] and
by Cannon and Nedergaard [2]. Changes in FA con-
centrations or in pH as factors were rejected because
they cannot explain the remarkable changes in GDP
binding. Mitochondrial swelling as reported by De-
sautels and Himms-Hagen [113] resulted in some
marginal changes in GDP-binding [106], but could
not be con¢rmed by others [108]. Similarly, the dif-
ference in GDP binding to UCP-1 proteins isolated
from warm- and cold-adapted rats reported by Swick
and Swick [108] and Feil and Rafael [93] could not
be reproduced in the our laboratory (unpublished
data). Here we will brie£y discuss the endogenous
ATP hypothesis advanced in our laboratory [91].
Evidence for the masking of UCP-1 by endoge-
nous ATP in isolated BAT mitochondria is based
on two observations [91]. First, the dissociation of
ATP but not ADP was extremely slow from mito-
Table 2
Parameters of nucleotide binding to UCP-1
Unsubstituted Dansyl-substituted DAN-ATP
GTP ATP GDP ADP GTP ATP ADP AMP
KD (WM) 0.45 1.5 0.90 2.3 0.30 0.81 1.4 2.1 2.1
K
0
c 30 8.2 15 2.4 14 2.3 1.4 0.09 0.2
KD and Kd are the overall dissociation constant and the dissociation constant of the loose complex, respectively. K
0
c is the ratio of
k1/k31 evaluated for the two-stage binding model UCPN
Kd
UCPWNk
1
k31
UCPWN. Data measured at pH 6.7 [88,89,92].
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chondria (koff = 2U1033 s31), as shown by chase ex-
periment and by successive washing at room temper-
ature. Thus endogenous ATP can remain bound to
the isolated mitochondria. Second, binding measure-
ments in various laboratories were performed under
non-equilibrium conditions, i.e., a too short incuba-
tion time [48,90,105,114] that did not allow equilibra-
tion of externally added ADP or GDP with endoge-
nous prebound ATP. The biphasic Scatchard plots
have been interpreted [91] to re£ect the non-equilib-
rium state where the ‘high a⁄nity’ sites represent
fast binding of GDP to the free UCP-1 sites in mi-
tochondria, and the ‘low a⁄nity’ site is due to com-
petition with the bound ATP. Only on removal of
the prebound ATP with an anion exchanger and
prolonged incubation (60 min) did the Scatchard
plots become linear with the same nucleotide speci-
¢city and similar pH dependence as reported for the
isolated protein. The non-linearity can be reintro-
duced by loading the mitochondria with low concen-
trations of ATP (1 to 10 WM).
Apparently BAT mitochondria isolated from
Fig. 7. Proposed mechanism for the masking/unmasking phenomena. At thermoneutrality (28‡C), the BAT mitochondria are supposed
to be largely coupled by ATP inhibition of the UCP-1. When the animals are acutely cold adapted or treated with norepinephrine,
FAs are released which can (1) directly interact with UCP-1 to enhance its H transport activity and (2) deplete ATP for FA activa-
tion. The acute drop in ATP concentration results in dissociation of bound ATP from UCP-1, yielding more free UCP-1 molecules.
The high FA and low ATP concentrations allow a high thermogenic activity in contrast to the low basal thermogenic activity at
28‡C. In isolated mitochondria, GDP binding (5 min incubation) measures the free UCP-1 sites whereas total binding sites are meas-
ured only after Dowex treatment and 60 min incubation (see [91]). Of the four states, only UCP-FA is functional as a H transporter.
Under the acute (6 1 h) adaptation conditions, the UCP-1 content remained constant as shown by gel electrophoresis and immuno-
logical analysis.
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acutely warm-adapted hamsters retained more en-
dogenous ATP than did the cold control, as shown
by the lower non-linear binding [91]. On Dowex
treatment, both mitochondria yielded the same
GTP binding a⁄nity and capacity, suggesting that
ATP was masking the binding sites. Furthermore,
the observed H transport activity correlated linearly
with GDP binding (5 min incubation) in mitochon-
dria loaded with a wide range of ATP concentrations
by Dowex treatment or ATP additions. Thus the
previous conclusion that GDP binding is an index
for the thermogenic capacity of the mitochondria
[115] can be adequately explained by endogenous
ATP masking of the UCP-1 sites.
A mechanism for the masking/unmasking phenom-
enon incorporating the ATP hypothesis and bio-
chemical ¢ndings is illustrated in Fig. 7. In the rest-
ing state at 28‡C, the mitochondria are coupled since
UCP-1 is largely inhibited by endogenous ATP. The
basal free FA concentrations are low [116]. A low
basal thermogenic activity is maintained by the small
number of free UCP-1 molecules. Upon acute cold-
adaptation at 4‡C or norepinephrine stimulation,
FAs are released [61,116] which can both activate
UCP-1 and deplete endogenous ATP by FA activa-
tion where ATP is converted to AMP. An acute and
large drop in endogenous ATP concentration was
reported [62,63,117,118], which would result in dis-
sociation of prebound ATP from UCP-1, thus un-
masking the binding sites. The mitochondria become
uncoupled and produced less ATP. In this state most
of the ATP is supplied by substrate-level phospho-
rylation [119], but mainly consumed for FA activa-
tion. The combined activation of UCP-1 by FA
and by unmasking of the binding sites lead to a
high mitochondrial conductance as observed by
Nicholls group [4]. The drop in FA concentration
and subsequent increase in ATP concentration
[119,120] initially provided by substrate-level phos-
phorylation will restore the mitochondria into the
coupled state.
5. E¡ects of amino acid reagents on nucleotide binding
and transport
A variety of amino acid reagents have been used to
elucidate the involvement of speci¢c amino acids in
nucleotide binding and H/Cl3 transport of UCP-1.
These studies have been performed on whole mito-
chondria, on isolated and reconstituted UCP-1 (Ta-
ble 3). After isolation of UCP-1, an obvious task was
probing the nucleotide binding site with amino acid
reagents. A weak inhibition of GDP binding was
observed with phenylglyoxal and a strong one with
the aggressive lysine reagent trinitrobenzene sulfo-
nate [10]. Most of these studies have been performed
on mitochondria where nucleotide binding and H/
Cl3 transport were measured by the swelling meth-
ods [121,122] or also directly [71]. There were strong
variations in the results depending on experimental
conditions and also whether the exposure of reagents
were more radical. For example, among Cys reagents
the more aggressive tetranitromethane inhibited
GDP binding quite strongly whereas N-ethylmalei-
mide (NEM) had an e¡ect only at very high concen-
trations [122]. No or only marginal inhibition of
H transport was observed by various groups
Table 3
E¡ects of amino acid reagents on UCP-1
Reagent Target E¡ect Reference
Phenylglyoxal Arg Weak inhibition of GDP binding [10]
Trinitrobenzene sulfonate TNBS Lys (Cys) Strong inhibition of GDP binding [10]
Diazobenzene sulfonate DABS Lys, Cys Inhibition of GDP binding; covalent incorporation of DABS [71]
Tetranitromethane NEM Cys Di¡erential e¡ect on inhibition of H/Cl3 transport of GDP [122]
Butanedione Arg Inhibition of GDP, abolition of H transport inhibition [123]
Photooxidation His Inhibition of GDP binding [10]
Diethylpyrocarbonate His Inhibition of GTP but not of GDP binding; speci¢c target H214 [125]
Mersalyl (mercurials) Cys Inhibition of H transport [124]
Hydrophobic NEM derivatives Cys Activation of H/Cl3 transport in UCP-1; Inhibition of GDP binding [122]
Woodward reagent K (WRK) ASP, Glu Speci¢c target E190; abolishes GTP, GDP binding [104]
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[10,71,123,121,122], whereas Jezek [124] reported in-
hibition with mersalyl. Possibly in this case a gener-
alized damage to UCP-1 occurred. More e¡ective
was another arginine reagent butanedione in the in-
hibition of GDP binding [123]. The most speci¢c in-
hibition of nucleotide binding was caused by the car-
boxyl modifying Woodward reagent K (WRK) [104].
Here in the isolated UCP-1 only a twofold molar
excess of WRK to UCP-1 was su⁄cient to com-
pletely block GTP and GDP binding. Further, with
WRK a speci¢c incorporation only into one residue
E190 was elucidated. WRK binding was visualized to
be promoted by the sulfonate group of WRK in
accordance with the particular a⁄nity of the nucleo-
tide pocket for sulfate. With this ¢nding and further
by mutagenesis, E190 was identi¢ed to be the pre-
dicted gatekeeper to the phosphate moiety binding
pocket [56]. The His reagent diethylpyrocarbonate
(DEPC) was also shown to have a highly speci¢c
target [125]. According to the prediction that this
His is involved in GTP binding but not in GDP
binding, DEPC inhibited GTP but not GDP binding.
DEPC did not inhibit H or Cl3 transport and
therefore, H145 and H147 are excluded as targets
for DEPC, since this His pair is essential for H
transport. Only the well conserved H214 is left as a
DEPC target. Obviously, H214 has a more favorable
environment for DEPC to alkylate the imidazole
moiety than the other histidines.
It can be generalized that the nucleotide binding
site is much more sensitive and more easily a¡ected
by amino acid reagent than H or Cl3 transport.
The latter are insensitive to most reagents unless
they are used under damaging conditions. On this
line, ¢rst Kopecky et al. [71], using diazobenzene
sulfonate (DABS) on mitochondria, and then Ka-
tiyar and Shrago [123], using butanedione in recon-
stituted UCP-1, concluded from the inhibition of
GDP binding and the insensitivity of H transport
that the nucleotide does not bind at the transport
site. This was shown also with WRK [104] and
DEPC [125] which did not a¡ect any transport but
completely abolished nucleotide binding. The
non-identity of the nucleotide binding site with the
transport site is also evident from the fact that nu-
cleotide derivatives, such as DAN-ATP and dansyl-
AMP, bind to UCP-1 but do not inhibit H trans-
port [33,88]. A minor e¡ect of FAs on MgATP bind-
ing was reported by Rial et al. [48]. However, as
these authors also pointed out, FAs do not act by
displacing nucleotides from UCP-1. A further argu-
ment is that in our hands no competition has been
observed (unpublished data) between nucleotides
and FAs.
6. Heterologous expression of UCP-1
For various reasons, in particular for mutagenesis,
heterologous expression of UCP-1 was attempted
and performed in various laboratories. The research
group of Ricquier tried to express UCP-1 in various
mammalian cell lines [126,127]. In Chinese hamster
ovary cells the expression of UCP-1 was detected in
the mitochondrial fraction, suggesting that UCP-1
was inserted into the mitochondria in these cell lines
[126]. However, the level of expression was low and
unsuitable for isolation of UCP-1 and characteriza-
tion of its function. Attempts to express UCP-1 in
Xenopus oocytes failed to produce viable UCP-1
[127]. UCP-1 was also expressed in Escherichia coli
using galactose or temperature-sensitive promoters
(Bienengraeber and Klingenberg, unpublished data).
In both cases high yields of UCP-1 were obtained in
inclusion bodies, as found with other mitochondrial
carriers expressed in E. coli [128^131]. The inclusion
bodies contained about 70% UCP-1. The protein
could be solubilized by sarcosyl and reconstituted
into vesicles, however no H transport activity could
be regained (unpublished data).
The most successful and widely used system for
UCP-1 expression so far is the Saccharomyces cere-
visiae. The start codon in the UCP-1 gene was
changed to conform with the yeast consensus se-
quence ATA ATG for obtaining good expression
levels [132]. By removing the 5P and 3P non-coding
sequences, expression levels of 24 Wg UCP-1/mg mi-
tochondrial proteins were obtained [133]. Garlid’s
group [134] claimed a high expression level of 70 to
100 Wg UCP-1/mg mitochondrial protein, after
changing the sequence around the start codon to
resemble the GAPDH gene. However this claim is
in contradiction to the GTP binding capacity meas-
ured by the same authors which corresponds to only
26 Wg UCP-1 per mg mitochondrial protein. Unless
UCP-1 is quanti¢ed by immunoassay, GTP binding
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capacity should be a good measure of UCP-1 content
provided precautions are taken for unmasking UCP-
1 from endogenous ATP [91].
The growth of the yeast transformants is some-
what or severely retarded after introduction of
UCP-1, according to the strength of promoting
UCP-1 expression [132]. These results suggest that
UCP-1 in situ does some uncoupling and thus a¡ects
cell growth. However, the fact that yeast cells grow
fairly well although UCP-1 is expressed indicates that
the uncoupling action of UCP-1 is inhibited to a
large extent by endogenous ATP. This presumption
is supported by the results of Bouillaud et al. [135]
that a UCP-1 mutant which does not bind nucleoti-
des has a higher uncoupling e¡ect on the yeast cells,
as measured by £ow cytometry.
From these yeast cells, mitochondria containing
UCP-1 were isolated in which the uncoupling proper-
ties were assessed by respiratory control, its response
to activation by FAs and inhibition by nucleotides
[56,133,135]. In general, the stimulation by FAs was
lower than in mitochondria from BAT. The uncou-
pling by UCP-1 in the yeast mitochondria was fur-
ther con¢rmed by measurements of the intracellular
mitochondrial membrane potential. H and Cl3
transport were assayed by mitochondrial swelling in
K acetate and KCl. Phosphate had to be included
to inhibit the ‘yeast uncoupling pathway’ [133].
Under these conditions GDP-sensitive swelling was
observed, which could be activated by palmitate. The
Cl3 transport dependent swelling was inhibited by
GDP and not activated by palmitate similarly to
what is the case in BAT mitochondria. All these ob-
servations suggest that the uncoupling and regula-
tory properties are preserved in UCP-1 expressed in
yeast mitochondria. Measurement of GDP binding
to these mitochondria revealed high and low a⁄nity
binding sites [133], similar to those observed in BAT
mitochondria [48,90].
From these yeast mitochondria UCP-1 has been
isolated and partially puri¢ed [56,79,134] with the
hydroxyapatite procedure. The binding of dansyl-
GTP and [14C]GTP to the isolated UCP-1 exhibited
a⁄nity and pH dependence [56] similar to the natural
hamster UCP-1 [64,88]. After reconstitution into pro-
teoliposomes the H transport activity was deter-
mined using pyranine as £uorescent pH probe [56],
or indirectly by the K counter£ow with a £uores-
cent K probe [69]. H transport rates estimated
with the latter method may be too low because of
other ion movements driven by K. Cl3 transport
activity was measured using Cl3 speci¢c £uorescent
probes [56,57].
6.1. Mapping the nucleotide binding site
Mapping the nucleotide binding site in UCP-1
with covalently interacting nucleotide derivatives
should have a good chance of success as compared
to the same approach in the AAC for two reasons.
First, the a⁄nity towards nucleotides is much higher
in UCP-1 than in AAC [136,137]; second, the ligand
tolerance for binding in UCP-1 is higher and thus
UCP-1 can accept nucleotides substituted with reac-
tive groups for covalent modi¢cation [138,139]. 8-
Azido ATP and still more 2-azido ATP compete
with GDP for the binding site at UCP-1. Speci¢c
photoa⁄nity labeling could be di¡erentiated from
the usual background by prior blocking of the nu-
cleotide binding site with GTP. Identifying the incor-
poration site posed considerable di⁄culties due to
the unusually high photolytic sensitivity and partial
resistance of UCP-1 towards cleavage by proteases
and BrCN [139]. Surprisingly, photoa⁄nity labeling
by 2- and 8-azido ATP in intact BAT mitochondria
was found in regions (T259 and T264) which, accord-
ing to the classical model of 6 transmembrane helical
folding, were supposed to be located on the matrix
side [138,139]. This seemed to be in contrast to the
well-de¢ned access of nucleotides only from the cy-
tosol. A similar paradox was noted previously with
the AAC, where 8- and 2-azido ATP labeled a sec-
tion located on the matrix side in the second domain
[136,137]. Both 8- and 2-azido ATP are supposed not
to be transported, however in AAC some transport
across the membrane cannot be excluded as rigor-
ously as in UCP-1. With 3P-O-(5-£uoro-2,4-dinitro-
phenyl)-ATP, a third residue, C253, could be cova-
lently labeled, which is also located in the matrix
section of the third domain near the photoa⁄nity
labeled T264 [138].
Already in the AAC, labeling of matrix localized
lysines with the membrane impermeable reagent pyr-
idoxal phosphate led to the conclusion [140] that part
of the matrix section forms a loop protruding into
the translocation channel area, thus becoming acces-
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sible from the c-side. Whereas in AAC evidence was
obtained for an intermembrane loop in the second
repeat domain, in UCP-1 the photoa⁄nity targets
were found in the third domain, suggesting that be-
cause of the three repeat structure, intermembrane
loops may occur in all three domains providing a
threefold lining for the translocation channel. To-
gether with the pH sensing residues E190 and H214
identi¢ed by mutagenesis [56,125], a total of ¢ve res-
idues have been de¢ned to be involved in nucleotide
binding. Four of them are localized in the third do-
main, only E190 resides on the fourth helix in the
second repeat domain. The positioning of ATP in
UCP-1 suggested by these mapping results is shown
in Fig. 8.
6.2. Site-directed mutagenesis
Mutagenesis of UCP-1 has been performed in
three di¡erent laboratories using the yeast expression
system. The work of Bouillaud and Ricquier’s labo-
ratory concentrated on manipulations of a UCP-1
within a putative consensus sequence 261 to 269
with the DNA-binding domain of an estrogen recep-
tor [135,141]. They argued that this region is similar
to the homologous region in AAC but that it does
not occur in the phosphate carrier. These residues
coincide with the matrix or intermembrane loop re-
gion in the third domain which was earlier associated
with the nucleotide binding site by photoa⁄nity la-
beling [138,139]. After deletion of the nine residues
(UCP-1v9), the growth of the yeast cells became very
poor, and a breakdown of the transmembrane poten-
tial could be monitored by £ow cytometry [135]. This
suggests that the intracellular nucleotide binding is
abolished by this deletion. Deletion of the three res-
idues F267, K268 and G269 is much less deleterious
and the cells still retained considerable growth activ-
ity. In the isolated mitochondria, palmitate-activated
swelling was measured without response to GDP,
suggesting that the three residues may be involved
in nucleotide binding. The single mutations F267Y
[135] and K268Q [142] did not a¡ect nucleotide bind-
ing. Thus, no single residue could be attributed to the
nucleotide binding in this region. The large deletions
may have caused structural changes which a¡ect nu-
cleotide binding in an unspeci¢c manner without
being part of the nucleotide binding site. Single mu-
tations of all seven cysteines in UCP-1 showed that
none of the cysteines is essential for activity
[133,143]. C304 was implied in FA activation because
2-bromopalmitate severely inhibited the growth of
the C304S mutant or several other mutants [144]. It
was proposed that this group is involved in binding
of FAs which activate H transport [144]. However,
this hypothesis was later retracted since it was shown
by Ricquier and Bouillaud [3], that truncated UCP-1
lacking the last 11 hydrophilic residues still retained
FA-activated H transport.
The intrahelical arginines present in the second
helix of each repeat domain are a striking signature
of the mitochondrial carrier family and therefore not
speci¢c to UCP-1. In UCP-1 mutation and neutrali-
zation of R276 had little e¡ect on H transport ac-
Fig. 8. Mapping of the binding site for nucleotide (ATP43) in
UCP-1 by identifying ¢ve residues that interact or participate in
nucleotide binding. Only the C-terminal half of UCP-1 is
shown. E190 and H214 regulate the access of the phosphate
moiety [56,79], C253 interacts near the ribose [138] and T259,
and T264 interacts near the adenine moieties [137].
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tivity but abolished inhibition by GTP [142,145].
Mutation of all three intrahelical repeat arginines
in UCP-1 was found not to a¡ect H transport,
while inhibition by GDP was abolished by all three
mutations [142]. No GDP binding to isolated UCP-1
was reported for the R82Q and R182T mutants
whereas surprisingly the R276L mutant fully retained
nucleotide binding [142]. However, this ¢nding could
not be con¢rmed by work from our laboratory (see
below) in which also the R276Q mutant displayed no
binding activity (Echtay and Klingenberg, unpub-
lished data).
It is important to note that all three Arg mutants
are expressed to a level of only 50% of the wild-type
as assayed by quantitative enzyme-linked immuno-
sorbent assay (ELISA) (Bienengraeber and Klingen-
berg, unpublished data). This resembles the much
stronger inhibition of expression of the yeast AAC2
caused by these mutations [146^148], indicating that
the main function of these arginines typical for the
mitochondrial carrier family resides in the biogenesis
process. Possibly, with their positive charge the argi-
nines may be required, during the import of UCP-1,
for the interaction with one of the outer or inner
membrane transport factors. The loss of nucleotide
a⁄nity may be caused only indirectly by replacement
of the arginines rather than indicating their partici-
pation in the binding process.
The rare case where site-directed mutagenesis
strikingly con¢rms a predicted residue function was
the identi¢cation of the postulated pH-regulating res-
idues for nucleotide binding. As discussed above,
based on the pH dependence two H dissociating
groups in UCP-1 were proposed to be involved in
nucleotide binding, a carboxyl group with a low
pKa, regulating access of both NDP and NTP, and
a His group with a pKaW7.2 regulating only NTP
binding [64,88]. With the help of the highly speci¢c
Woodward reagent K, the carboxyl group was iden-
ti¢ed as E190 located within the fourth helix [104].
Mutational neutralization [56] in E190N largely
abolished the pH dependence of nucleotide binding
and increased the a⁄nity at pHs 7, exactly as would
be predicted from the role of E190 as a gatekeeper
for the phosphate moiety binding niche. Accordingly,
the inhibition relief of H transport by high pH was
abolished. Mutation of H214 within helix 5 and pos-
sibly quite close to E190 decreased pH dependence of
binding only for NTP but not for NDP [79], in ac-
cordance with the prediction that this His is involved
in interaction only with the Q-phosphate. However,
di¡erent from the prediction, the binding is retained
on replacement of the His with Glu in H214N and
therefore it was concluded that H214 in the proto-
nated form (HisH) is not interacting with the
Q-phosphate, but rather that in the neutral form it
protrudes into the Q-phosphate region. On lowering
the pH, the HisH is assumed to be retracted by a
background negative charge (Fig. 6). Therefore, the
substitution of this His by a smaller residue as in
H214N does not prevent binding whereas substitu-
tion by a larger residue such as Trp in H214W
strongly decreases the a⁄nity for NTP but not for
NDP [125]. It should be pointed out that mutation of
neither E190 nor H214 a¡ects H or Cl3 transport,
although both are intrahelical H dissociating
groups. The results also stress that not only the nu-
cleotide binding site but also its regulation by H
dissociation is segregated from the groups involved
in the H translocation. It should be noted that E190
and H214 are conserved in UCP-1 from all sources
found so far as well as in the UCP-2 [5] and UCP-3
[6,149] isoforms, indicating that they may share a
similar pH control of nucleotide binding.
A His pair, H145 and H147, is located in the sec-
ond domain in the middle of the hydrophilic matrix
region. Replacement of the His in H147N decreased
H transport drastically to only about 20%, while
Cl3 transport activity and nucleotide binding were
both una¡ected [79]. The double mutant
H145Q+H147N decreased H transport to only
12%. Interestingly, these two His are absent in
UCP-2 and UCP-3 and are replaced by one Arg,
with the exception of human UCP-3 where the ho-
molog to H145 is retained. Another potential H
donor/acceptor conserved in all UCP versions is
D27 localized in the ¢rst transmembrane helix. It is
highly characteristic for UCP; at the same position a
rare intrahelical Lys is localized as a marker for
AAC. This Lys has been found to be essential for
AAC transport activity [146]. In UCP-1 mutational
neutralization in D27N drastically reduced H trans-
port activity to about 20% but did not markedly
a¡ect Cl3 transport (Echtay and Klingenberg, un-
published data). Further, GTP binding was still re-
tained to about 60%. By these studies at least two
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H accepting groups have been identi¢ed which can
be linked to H transport.
Other acidic and basic residues were converted
into neutral residues with varying defects on the
GTP binding [56,79,111,135,145]. Summarizing the
results from mutational studies on about 30 di¡erent
charged residues, it can be concluded that the hit rate
of a¡ecting functionality is high. In general, the nu-
cleotide binding site is more sensitive to mutations
than the H or Cl3 transport. Typical for mitochon-
drial carriers, UCP-1 within its comparatively small
size of 306 residues has little redundancy but a well
equilibrated network of charged residues necessary
for the uncoupling and regulatory functions. The
same experience of an extraordinary high mutational
hit rate has been made previously with the AAC
[146^148].
7. Outlook
There are two major avenues of interest on UCP-
1, the mechanism of H transport and its physiolog-
ical role and regulation. Despite the progress re-
ported in this review, there are still large lacunae in
both ¢elds. Within the realms of H transport mech-
anisms explored in many other systems, UCP-1 ex-
cels by its dependence on FAs which are interesting,
but di⁄cult to elucidate ligands. Whereas site-di-
rected mutagenesis may assist at the present stage
in ruling out alternatives of H transport models, a
more penetrating insight can only come from the
knowledge of the three-dimensional structure.
Many years of attempts in several laboratories to
solve the structure of the homologous AAC have
failed so far. Actually, up to now no three-dimen-
sional structure for any transporter is known.
The physiological role of UCP-1 and its regulation
in the thermogenic BAT is still a vexing problem
which has come again into focus by the discovery
of UCP-2 and UCP-3 in other tissues. Regulation
of H transport by FA is obvious for UCP-1 and
also inferred from the close relationship of the UCP-
2 and UCP-3 expression with the FA levels [150^
152]. Although the mechanism of function of UCP-
2 and UCP-3 is still unknown, there are good indi-
cations in the sequence structure that both are sim-
ilar to UCP-1. Once their function is also elucidated,
a comparison between all UCP-1 will give a positive
feedback also for understanding the role of UCP-1.
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